Entreprise française

AN INTERNATIONAL COMPANY IN THE SUPPLY OF RESEARCH CHEMICAL COMPOUNDS

A FRENCH COMPANY WITH INTERNATIONAL EXPERTISE IN THE SUPPLY OF RESEARCH CHEMICALS

AMBINTER IS A BRAND OF GREENPHARMA FROM 2011 and a global provider of advanced chemicals

about Ambinter

Ambinter is a global provider of advanced chemicals for drug discovery applications. We have over 25 years of experience.

Our database contains over 46 million compounds for high-throughput screening, building blocks, as well as a wide selection of fragments and natural products.

Ambinter's strategy is to offer sophisticated and rare chemicals with high relevance to biological activities.

Our experience in chemical supply ensures that you will have the chemicals you need when you need them.

...

greenpharma

Greenpharma is an R&D solution provider in terms of products and services. The core expertise is based on the knowledge of natural substances and a multidisciplinary technical platform. It allows us to leverage this knowledge in the discovery of active molecules or ingredients for the pharmaceutical, cosmetic and food industries. With the support of Greenpharma, Ambinter will be able to offer other valuable services, such as custom synthesis, chemoinformatics and molecular modelling, analytical chemistry, R&D project management, etc. Do not hesitate to contact us if you need more information.

...

Ambinter team

Ambinter was acquired and became a brand of Greenpharma SAS on July 1, 2011.

...
46 million compounds for virtual screening
we offer sophisticated and rare chemical products
over 25 years of experience

check out our catalogues

Building blocks

A selection of millions of Building blocks

Screening

an offer of multiple screening libraries in solution

Natural compounds

access to highly structural diverse natural compounds

keep up to datewith the latest news

...
2023-06-23 14:44:10

Ambinter supplied FLIPinB

more
...
2022-01-28 09:11:00

Application of an integrated cheminformatics-molecular docking approach for discovery for physicochemically similar analogs of fluoroquinolones as putative HCV inhibitors.

more
...
2022-01-28 09:11:00

Discovery of New non-steroidal selective glucocorticoid receptor agonists

more